| 000 | 01643 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515033448.0 | ||
| 264 | 0 | _c20070508 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2006.053470 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVander Cruyssen, Bert | |
| 245 | 0 | 0 |
_aPrediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cMar 2007 |
||
| 300 |
_a364-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnosis |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 |
_aEpitopes _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xgenetics |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides, Cyclic _ximmunology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRheumatoid Factor _xblood |
| 700 | 1 | _aHoffman, Ilse E A | |
| 700 | 1 | _aPeene, Isabelle | |
| 700 | 1 | _aUnion, Ann | |
| 700 | 1 | _aMielants, Herman | |
| 700 | 1 | _aMeheus, Lydie | |
| 700 | 1 | _aDe Keyser, Filip | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 66 _gno. 3 _gp. 364-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2006.053470 _zAvailable from publisher's website |
| 999 |
_c16431370 _d16431370 |
||